Skip to search.
 TSX Down 0.39% TSX Ventures Up 0.28%

Amgen Inc. (AMGN)

-NasdaqGS
162.59 Up 2.04(1.27%) Mar 27, 4:00PM EDT
|After Hours : 162.02 Down 0.57 (0.35%) Mar 27, 7:12PM EDT
Add to Portfolio
Prev Close:160.55
Open:161.26
Bid:160.55 x 100
Ask:162.98 x 100
1y Target Est:176.42
Beta:0.58
Next Earnings Date:21-Apr-15AMGN Earnings announcement
Day's Range:161.00 - 163.45
52wk Range:108.20 - 173.14
Volume:2,438,867
Avg Vol (3m):3,491,220
Market Cap:123.38B
P/E (ttm):24.27
EPS (ttm):6.70
Div & Yield:3.16 (1.90%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AMGNUp 1.27%123.38B
JNJUp 0.20%278.99B
NVSUp 0.84%240.82B
TEVADown 0.70%52.80B

Key Statistics

Forward P/E (1 yr):15.51
P/S (ttm):6.07
Ex-Dividend Date:12-May-15

Analysts

Annual EPS Est (Dec-15) :9.31
Quarterly EPS Est (Mar-15) :2.10
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.55

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular,... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback